BioNTech cuts 2023 revenue target on reduced prospects for vaccine
FRANKFURT (Reuters) – BioNTech has cut its 2023 revenue target by about 1 billion euros ($1.1 billion) on lower demand for the COVID-19 vaccine made …
biontech
BioNTech, Pfizer sue CureVac in U.S. over COVID-19 vaccine patent claims
By Ludwig Burger FRANKFURT – COVID-19 vaccine maker BioNTech said on Tuesday that it and partner Pfizer have filed a complaint with the U.S. District …
BioNTech, Pfizer to start testing universal vaccine for coronaviruses
By Ludwig Burger (Reuters) -Germany’s BioNTech, Pfizer’s partner in COVID-19 vaccines, said the two companies would start tests on humans of next-generation shots that protect …